Predictions
Nestle Nam. ADR
Start price
Target price
Perf. (%)
€105.50
15.06.21
15.06.21
-
15.06.24
15.06.24
-6.16%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Hudson Technolgies Inc.
Start price
Target price
Perf. (%)
€3.10
09.03.23
09.03.23
€13.23
09.03.24
09.03.24
-
10.03.24
10.03.24
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€2.76
15.04.22
15.04.22
-
15.04.23
15.04.23
-90.72%
16.04.23
16.04.23
Nestle Nam. ADR
Start price
Target price
Perf. (%)
€117.00
16.01.22
16.01.22
€100.00
16.01.23
16.01.23
-2.56%
17.01.23
17.01.23
Probably not worthwhile Investment
Below average Management
Sustainability is not important
Higher risks for its business
Nestle Nam. ADR
Start price
Target price
Perf. (%)
€117.00
31.08.22
31.08.22
€108.00
30.11.22
30.11.22
-3.42%
30.11.22
30.11.22
The Alkaline Water Co.inc.
Start price
Target price
Perf. (%)
€6.78
08.07.22
08.07.22
€0.000
08.07.23
08.07.23
-23.45%
26.09.22
26.09.22
Nestle Nam. ADR
Start price
Target price
Perf. (%)
€119.00
09.12.21
09.12.21
€100.00
09.12.22
09.12.22
-1.68%
31.08.22
31.08.22
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€1.88
02.05.22
02.05.22
€32.00
02.05.23
02.05.23
-24.47%
02.06.22
02.06.22
Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€2.10
09.05.22
09.05.22
€3.30
09.05.23
09.05.23
-18.57%
16.05.22
16.05.22
Could be very worthwhile Investment >20% year
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€1.98
11.04.22
11.04.22
€0.000
11.04.23
11.04.23
-5.05%
02.05.22
02.05.22
Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€2.76
16.04.22
16.04.22
€0.000
16.04.23
16.04.23
-44.57%
30.04.22
30.04.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€1.98
11.04.22
11.04.22
€0.000
11.04.23
11.04.23
39.39%
18.04.22
18.04.22
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€1.23
25.12.21
25.12.21
€2.00
25.12.22
25.12.22
-11.38%
08.01.22
08.01.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Ocean Bio-Chem Inc.
Start price
Target price
Perf. (%)
€10.60
13.12.20
13.12.20
€12.00
13.12.21
13.12.21
-28.29%
14.12.21
14.12.21
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€2.70
25.08.21
25.08.21
€2.80
04.11.21
04.11.21
-15.56%
05.11.21
05.11.21
The Alkaline Water Co.inc.
Start price
Target price
Perf. (%)
€17.85
23.10.20
23.10.20
€22.50
04.11.21
04.11.21
20.17%
05.11.21
05.11.21
Nestle Nam. ADR
Start price
Target price
Perf. (%)
€101.50
20.08.20
20.08.20
€110.00
04.11.21
04.11.21
16.26%
05.11.21
05.11.21